All In MedTech

FDA Clearance Tracker · P170003-S026

Lutonix Drug Coated Balloon PTA Catheter

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 29, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 29, 2024

Approved

Time to decision

539 days

Received Mar 9, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P170003-S026
Device name
Lutonix Drug Coated Balloon PTA Catheter
Applicant
Lutonix
Applicant location
New Hope, MN
Received
Mar 9, 2023
Decided
Aug 29, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P170003

Device type

Device class
Class III

Every decision under product code PRC

FDA's approval statement

As written in FDA's record.

approval for changes to the labeling of the Lutonix 035 Drug Coated Balloon (DCB) PTA Catheter (Model 9010) and Lutonix 018 DCB PTA Catheter (Model 9014) to include results of the Lutonix Global AV Registry

Source documents

Other decisions for Lutonix

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.